---
$id: https://graph.org.ai/products/commodity/51151512
$type: Product
source: UNSPSC
code: "51151512"
title: "Neostigmine"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Neostigmine

**UNSPSC Code**: 51151512
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an acetylcholinesterase inhibitor with the molecular formula C12H19N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3982TWQ96G, chemically known as 3-trimethylammoniumphenyl n,n-dimethylcarbamate but generally known as neostigmine, which bears US NIH Compound Identifier 4456. European Medicines Agency schedules Neostigmine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03411MIG. World Health Organization schedules neostigmine in its Anatomical Therapeutic Chemical (ATC) Classification. NEOSTIGMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, NEOSTIGMINE remains the US FDA Preferred Term for this commodity. Neostigmine bears US NLM identifiers UMLS ID C0027679 and NCI Concept Code C75024. SMILES: CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.

